Photofrin Injection, Powder, For Solution
NDC Package 76128-155-75
Package Information
Photofrin (porfimer sodium) injection is pHOTOFRIN® is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their healthcare provider, cannot be satisfactorily treated with Nd:YAG laser therapy. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Pinnacle Biologics, Inc., this product is identified by NDC 76128-155 and is authorized under FDA application NDA020451.
Identification & Billing
- RxCUI: 242166 - porfimer sodium 75 MG Injection
- RxCUI: 687066 - PHOTOFRIN 75 MG Injection
- RxCUI: 687066 - porfimer sodium 75 MG Injection [Photofrin]
- RxCUI: 687066 - Photofrin 75 MG (as porfimer sodium) Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76128 - Pinnacle Biologics, Inc.
- 76128-155 - Photofrin
- 76128-155-75 - 1 VIAL in 1 BOX, UNIT-DOSE / 31.8 mL in 1 VIAL
- 76128-155 - Photofrin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76128-155-75 identifies a specific commercial package of 1 vial in 1 box, unit-dose / 31.8 ml in 1 vial of Photofrin, a human prescription drug labeled by Pinnacle Biologics, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, for solution is formulated for intravenous use and contains porfimer sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pinnacle Biologics, Inc. on December 27, 1995. The current certification is valid through December 31, 2027.
How is this Pinnacle Biologics, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76128015575. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.